/ WHAT YOU WILL RECEIVE
Real photographs of your peptides — boxed, lot-labeled, and shipped in plain unmarked packaging from our partner research lab.
More batch photos and lab footage coming soon.
PEPTIDE SEQUENCE · STRUCTURE NOTE
GEPPPGKPADDAGLV (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val)
15-amino-acid pentadecapeptide isolated from a protective protein in human gastric juice. Exceptional pH stability, no disulfide bonds.
⏱ HALF-LIFE · PHARMACOKINETIC PROFILE
Healing pentadecapeptide (gastric origin)
~4–6 hours
Short systemic half-life · effects appear cumulative over multi-week protocols.
Healing Peptides · RESEARCH GRADE
BPC-157
10mg · Lyophilized Vial
Sold Out
This variant is temporarily unavailable — drop your email below to get notified.
BPC-157 (Body Protection Compound) — 15-amino-acid pentadecapeptide for regenerative research.
UNIT PRICE
$48 USD
≈ CA$66
Reconstitution required
This compound requires bacteriostatic water for reconstitution. Don't forget to add a 10mL vial of BAC water to your order — available in Lab Supplies.
HOW LONG WILL IT LAST YOU?
Enter your research protocol and vial quantity — see exactly how many weeks your order covers.
Each 10mg vial lasts
20 days
Your 10mg vial lasts
20days
≈ 20 days · 20 doses per vial
FOR RESEARCH USE ONLY
Not for human consumption. Intended for laboratory and in-vitro research applications./ RESEARCH INFORMATION · STANDARDIZED PROFILE
Full breakdown.
Every compound on Helixora ships with a consistent six-section research profile so you can compare and reference quickly.
Overview & Classification
Body Protection Compound 157 — synthetic 15-residue partial sequence isolated from human gastric juice.
Type
Synthetic pentadecapeptide
Derivation
Solid-phase peptide synthesis. Stable in gastric juice (unique for peptides).
Structural
GEPPPGKPADDAGLV — 15 amino acids, no disulfide bonds, exceptional pH stability.
Mechanism of Action
- ·Upregulates VEGFR2 expression → angiogenesis pathway activation
- ·Modulates nitric oxide system — implicated in vascular and cytoprotective effects
- ·Interacts with growth-hormone receptor pathway in fibroblast tissue
- ·Stabilizes serotonergic and dopaminergic systems in CNS research models
Research Highlights
- ·Tendon and ligament repair acceleration in animal models
- ·GI mucosal protection / repair in ulcer-induced research models
- ·Neurological recovery markers in TBI research
- ·Fibroblast migration and collagen synthesis enhancement in vitro
Research Usage Parameters
- ·Research dose range: 200–500mcg/day subcutaneous (local or systemic)
- ·Frequency: typically once or twice daily
- ·Cycle duration: 4–8 weeks; well-tolerated in extended research
Pharmacological Profile
Half-life
Short systemic half-life (~30 minutes)
Absorption
Subcutaneous, oral (gastric-stable), and intramuscular routes researched
Distribution
Wide tissue distribution — particularly in injured/inflamed tissue
Safety Profile
- ·Generally well-tolerated across research literature
- ·Mild injection-site reactions reported occasionally
- ·Long-term safety data limited — extended-protocol research ongoing
/ RESEARCH DOSSIER